Sigyn Therapeutics annual free cash flow
2014
2015
2018
2021
Sigyn Therapeutics Free Cash Flow (FCF) History (SIGY)
Sigyn Therapeutics reported −$1.8M in free cash flow for fiscal 2021, a decrease of $1.5M from the previous fiscal year.
View full Sigyn Therapeutics company overviewSigyn Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2021 | 2021-12-31 | −$1.8M | −$1.5M | — | — |
| 2018 | 2018-12-31 | −$289,062 | −$202,791 | — | −1019.69% |
| 2015 | 2015-12-31 | −$86,271 | −$38,366 | — | −295.38% |
| 2014 | 2014-12-31 | −$47,905 | — | — | −111.01% |
Sigyn Therapeutics quarterly free cash flow
Q1.16
Q2.16
Q3.16
Q1.18
Q2.18
Q3.18
Q1.21
Q2.21
Q3.21
Q4.21
Q3.22
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2022 | 2022-09-30 | −$524,168 | −$246,873 | — | — |
| Q4 2021 | 2021-12-31 | −$562,020 | −$564,111 | — | — |
| Q3 2021 | 2021-09-30 | −$557,021 | −$481,373 | — | — |
| Q2 2021 | 2021-06-30 | −$407,110 | −$298,676 | — | — |
| Q1 2021 | 2021-03-31 | −$277,295 | −$170,859 | — | — |
| Q3 2018 · Sep 30 | 2017-09-30 | $2,091 | $167,672 | — | +0.82% |
| Q2 2018 · Jun 30 | 2017-06-30 | −$75,648 | $245,204 | — | −17.49% |
| Q1 2018 · Mar 31 | 2017-03-31 | −$108,434 | — | — | −40.32% |
| Q3 2016 | 2016-09-30 | −$106,436 | — | — | — |
| Q2 2016 | 2016-06-30 | −$165,581 | — | — | — |
| Q1 2016 | 2016-03-31 | −$320,852 | — | — | — |
Sigyn Therapeutics free cash flow growth trends
Sigyn Therapeutics's latest reported quarter, Q3 2022, generated −$524,168 in free cash flow, a decrease of $246,873 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Sigyn Therapeutics filings at SEC.gov ↗